CA1027946A - Process for the preparation of 5-fluorouracil derivatives - Google Patents
Process for the preparation of 5-fluorouracil derivativesInfo
- Publication number
- CA1027946A CA1027946A CA214,712A CA214712A CA1027946A CA 1027946 A CA1027946 A CA 1027946A CA 214712 A CA214712 A CA 214712A CA 1027946 A CA1027946 A CA 1027946A
- Authority
- CA
- Canada
- Prior art keywords
- preparation
- fluorouracil derivatives
- fluorouracil
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13279573A JPS5324951B2 (US20020095090A1-20020718-M00002.png) | 1973-11-28 | 1973-11-28 | |
| JP13279673A JPS5324952B2 (US20020095090A1-20020718-M00002.png) | 1973-11-28 | 1973-11-28 | |
| JP4661774A JPS5512015B2 (US20020095090A1-20020718-M00002.png) | 1973-11-28 | 1974-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1027946A true CA1027946A (en) | 1978-03-14 |
Family
ID=27292666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA214,712A Expired CA1027946A (en) | 1973-11-28 | 1974-11-27 | Process for the preparation of 5-fluorouracil derivatives |
Country Status (7)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2602175B2 (de) * | 1975-01-22 | 1978-05-03 | Asahi Kasei Kogyo K.K., Osaka (Japan) | 1 -Alkanoyl-5-fluor-uracilderivate und ihre Verwendung |
| US4124765A (en) * | 1975-05-13 | 1978-11-07 | Ono Pharmaceutical Co., Ltd. | 5-Fluorouracil derivatives |
| US4071519A (en) * | 1975-11-05 | 1978-01-31 | Mitsui Toatsu Chemicals, Incorporated | 1-Carbamoyl-5-fluorouracil derivatives |
| JPS5331676A (en) * | 1976-09-06 | 1978-03-25 | Mitsui Toatsu Chem Inc | Uracil derivatives and their preparation |
| JPS6052708B2 (ja) * | 1976-12-24 | 1985-11-20 | エーザイ株式会社 | ５−フルオロウラシル系化合物およびそれを含有する抗腫瘍剤 |
| EP0010941B1 (en) * | 1978-10-30 | 1982-05-12 | Fujisawa Pharmaceutical Co., Ltd. | 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions |
| US4349552A (en) | 1978-10-30 | 1982-09-14 | Fujisawa Pharmaceutical Company, Ltd. | 5-Fluorouracil derivatives, and their pharmaceutical compositions |
| US4307098A (en) * | 1978-12-14 | 1981-12-22 | Imperial Chemical Industries Limited | Pesticidal compositions and processes for treating plants |
| JPS5663966A (en) * | 1979-10-29 | 1981-05-30 | Tokyo Kinzoku Kogyo Kk | Pyrimidine derivative and its preparation |
| JPS5767578A (en) * | 1980-10-09 | 1982-04-24 | Grelan Pharmaceut Co Ltd | N-phthtalidy-5-fluorouracil derivative |
| JPS5785374A (en) * | 1980-11-18 | 1982-05-28 | Mitsui Toatsu Chem Inc | 5-fluorouracil derivative and its preparation |
| FR2539412B1 (fr) * | 1983-01-13 | 1986-02-21 | Shoichiro Ozaki | Derives du 5-fluoruracile et leurs utilisations therapeutiques en tant qu'agents carcinostatiques |
| DE3301107A1 (de) | 1983-01-14 | 1984-07-19 | Ozaki, Shoichiro, Ehime | Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind |
| DE3347795A1 (de) * | 1983-01-14 | 1985-08-01 | Ozaki, Shoichiro, Ehime | Neue 1-(n-substituierte carbamoyl)-5-fluorouracil-derivate und krebshemmende mittel, in denen sie als aktive bestandteile enthalten sind |
| SU1235864A1 (ru) * | 1983-03-11 | 1986-06-07 | Отделение ордена Ленина института химической физики АН СССР | Нитроксильные производные 5-фторурацила,обладающие противоопухолевой активностью |
| WO1989010361A1 (en) * | 1988-04-27 | 1989-11-02 | Kyowa Hakko Kogyo Co., Ltd. | Novel compound and medicine containing same |
| HRP970239B1 (en) * | 1997-05-09 | 2004-04-30 | Inst Ru Er Bouekovic | Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity |
| ES2263238T3 (es) * | 1998-03-30 | 2006-12-01 | F. Hoffmann-La Roche Ag | Procedimiento para la preparacion de antagonistas alfail-adrenoceptores. |
| WO2000027403A1 (en) * | 1998-11-12 | 2000-05-18 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a pyrimidine analog |
| US6235776B1 (en) | 1998-11-12 | 2001-05-22 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| US6235782B1 (en) | 1998-11-12 | 2001-05-22 | Rifat Pamukcu | Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| WO2008100591A2 (en) * | 2007-02-14 | 2008-08-21 | The General Hospital Corporation | Modulation of nitric oxide signaling to normalize tumor vasculature |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3360520A (en) * | 1964-05-01 | 1967-12-26 | Du Pont | 1, 3, 5, 6-tetrasurbstituted uracils |
-
1973
- 1973-11-28 JP JP13279573A patent/JPS5324951B2/ja not_active Expired
- 1973-11-28 JP JP13279673A patent/JPS5324952B2/ja not_active Expired
-
1974
- 1974-04-26 JP JP4661774A patent/JPS5512015B2/ja not_active Expired
- 1974-11-22 DE DE2455423A patent/DE2455423C3/de not_active Expired
- 1974-11-25 US US05/527,143 patent/US3971784A/en not_active Expired - Lifetime
- 1974-11-26 GB GB51218/74A patent/GB1487335A/en not_active Expired
- 1974-11-27 CH CH1574274A patent/CH601258A5/xx not_active IP Right Cessation
- 1974-11-27 CA CA214,712A patent/CA1027946A/en not_active Expired
-
1975
- 1975-01-06 FR FR7500250A patent/FR2255910B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5324951B2 (US20020095090A1-20020718-M00002.png) | 1978-07-24 |
| FR2255910B1 (US20020095090A1-20020718-M00002.png) | 1978-07-21 |
| JPS5083379A (US20020095090A1-20020718-M00002.png) | 1975-07-05 |
| GB1487335A (en) | 1977-09-28 |
| JPS5324952B2 (US20020095090A1-20020718-M00002.png) | 1978-07-24 |
| US3971784A (en) | 1976-07-27 |
| CH601258A5 (US20020095090A1-20020718-M00002.png) | 1978-06-30 |
| DE2455423A1 (de) | 1975-06-05 |
| DE2455423B2 (de) | 1977-10-13 |
| JPS50148365A (US20020095090A1-20020718-M00002.png) | 1975-11-27 |
| DE2455423C3 (de) | 1978-06-08 |
| JPS5512015B2 (US20020095090A1-20020718-M00002.png) | 1980-03-29 |
| FR2255910A1 (US20020095090A1-20020718-M00002.png) | 1975-07-25 |
| JPS5088078A (US20020095090A1-20020718-M00002.png) | 1975-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1027946A (en) | Process for the preparation of 5-fluorouracil derivatives | |
| CA989827A (en) | Process for the preparation of 14-hydroxymorphinan derivatives | |
| CA1027951A (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine | |
| CA1027950A (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine | |
| EG11318A (en) | Process for the preparation of 7-amino-3-cephem derivatives | |
| CA1032156A (en) | Process for the preparation of 7-acylaminodesace-toxycephalosporanic acid derivatives | |
| CA1027952A (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-oxopiperidine | |
| CA1014974A (en) | Process for the preparation of 5-chloro-2-toluidine | |
| CA1036169A (en) | Process for the preparation of poly-n-alkyliminoalanes | |
| CA1033742A (en) | Process for the preparation of quinoline derivatives | |
| CA1029018A (en) | Process for the preparation of benzothiadiazines | |
| CA1022946A (en) | Process for the preparation of new derivatives for thiazole 5-methanol | |
| CA993871A (en) | Process for the preparation of certain indolobenzazepine derivatives | |
| CA1019726A (en) | Process for the preparation of methylcobalamine from cyanocobalamine | |
| CH609345A5 (en) | Process for the preparation of pyrimidinoaminomethylergoline derivatives | |
| ZA743764B (en) | Process for the preparation of antibiotic derivatives | |
| CA1021770A (en) | Process for the preparation of desmosterol derivatives | |
| CH610326A5 (en) | Process for the preparation of novel 4-oxo-1-pyridinylpenicillin and -cephalosporin derivatives | |
| CA1034497A (en) | Process for the preparation of choleragen | |
| CA1018165A (en) | Process for the manufacture of pyrimidine derivatives | |
| CA1022867A (en) | Microbiological process for the preparation of oxoalkylxanthines | |
| CA1035362A (en) | Process for the preparation of 1,2,4-triazole derivatives | |
| CH612956A5 (en) | Process for the preparation of 1H-tetrazole-5-thiol derivatives | |
| CA1026344A (en) | Process for the preparation of oxadiazoline derivatives | |
| AU487964B2 (en) | Process for the preparation of 7-amino- 3 - cephem derivatives |